Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$6,584,915
+$298,367 QoQ
Shares Held
26,168
-9.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#1,144
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PROFUND ADVISORS LLC holds $71,666,047 across 14 Drug Manufacturers - General names. ABBV ranks #5 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
51,320 | $18,583,998 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
110,868 | $14,007,063 | |
| 3 | LLY |
ELI LILLY & Co
|
9,538 | $11,440,164 | |
| 4 | JNJ |
Johnson & Johnson
|
32,688 | $8,301,771 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
26,168 | $6,584,915 | |
| 6 | MRK |
Merck & Co., Inc.
|
33,549 | $4,311,046 | |
| 7 | BIIB |
Biogen Inc.
|
8,560 | $1,849,473 | |
| 8 | PFE |
Pfizer Inc
|
73,381 | $1,767,014 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,584,915 | 26,168 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $6,286,548 | 28,905 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $8,913,394 | 39,010 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $7,281,701 | 31,449 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $6,441,385 | 34,702 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $7,270,553 | 34,701 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $7,119,728 | 40,066 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,861,322 | 44,872 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,062,126 | 47,004 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,446,522 | 35,401 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $5,959,061 | 38,453 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,537,429 | 37,149 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,225,907 | 38,788 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $5,700,186 | 35,767 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $33,501,914 | 207,301 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $27,258,587 | 203,104 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $32,453,378 | 211,892 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $37,943,952 | 234,063 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $34,918,441 | 257,891 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $32,403,500 | 300,394 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $35,489,935 | 315,074 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $35,041,203 | 323,796 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $40,246,182 | 375,606 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $30,105,033 | 343,704 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $39,971,925 | 407,129 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $22,194,680 | 291,307 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||